Interestingly, (R)-flurbiprofen is a COX-2 SSI with negligible effects on AA metabolism [14] which showed COX-2-independent anti-inflammatory effects in AD and experimental autoimmune encephalomyelitis multiple sclerosis models [63-65]. Here, PTGS2 is linked to multiple sclerosis.